GlassScriptPhysician profile
Sara Mccann
NPI 1427410430
$3,362.45
in general payments reported to CMS, 2019-2025
14 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.76 · 2023: $1,697 · 2024: $1,171 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,387 · Travel and Lodging: $621 · Consulting Fee: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,386.57 |
| Travel and Lodging | $621.12 |
| Consulting Fee | $290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,234.08 | 2023-2025 | Alphavac, Angiovac |
| W. L. Gore & Associates, INC. | $894.36 | 2023-2024 | Product In Development, Gore Tag Conformable Thoracic Endoprosthesis, Gore Viatorr Tips Endoprosthesis |
| Medtronic, INC. | $420.85 | 2022-2025 | Heli-Fx Endoanchor System, Concertotm, Endurant Iis |
| Penumbra, INC. | $228.92 | 2024 | Penumbra System, Indigo System |
| Silk Road Medical, INC. | $189.13 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Surmodics, INC. | $125.65 | 2024-2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Abbott Laboratories | $65.07 | 2025 | Esprit |
| Asahi Intecc USA, INC. | $62.40 | 2025 | Asahi Coronary Wires |
| Becton, Dickinson and Company | $43.99 | 2024 | Lutonix Drug Coated Balloon, Covera |
| Ge Healthcare | $30.11 | 2024 | |
| Stryker Corporation | $19.27 | 2025 | Flowtriever |
| Chiesi USA, INC. | $18.98 | 2025 | Cleviprex, Kengreal |
| Boston Scientific Corporation | $16.21 | 2024 | Embold Fibered |
| Philips North America LLC | $13.43 | 2024 | (Cj7) Intact Vascular Undivided |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Mccann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.